-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Downgrades Theravance Biopharma to Perform

Benzinga·03/05/2026 17:59:21
Listen to the news
Oppenheimer analyst Trevor Allred downgrades Theravance Biopharma (NASDAQ:TBPH) from Outperform to Perform.